XML 15 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Stockholders’ Deficit (unaudited) - USD ($)
$ in Thousands
Total
Preferred Stock
Common Stock
Treasury Stock
Additional paid-in capital
Accumulated deficit
Preferred stock, beginning balance (in shares) at Dec. 31, 2022   0        
Beginning balance at Dec. 31, 2022 $ 4,052 $ 0 $ 17 $ 0 $ 9,078 $ (5,043)
Common stock, beginning balance (in shares) at Dec. 31, 2022     173,524,360      
Treasury stock, beginning balance (in shares) at Dec. 31, 2022       0    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss) income and comprehensive (loss) income (32,899)         (32,899)
Interest on the promissory note to a member (282)       (282)  
Repayment of promissory note to a member 18,833       18,833  
Payment of interest on promissory note to a member 520       520  
Stock-based compensation 3,126       3,126  
Vested restricted stock units (in shares)     21,875      
Exercise of stock options (in shares)     296,477      
Exercise of stock options 1,010       1,010  
Preferred stock, ending balance (in shares) at Mar. 31, 2023   0        
Ending balance at Mar. 31, 2023 (5,640) $ 0 $ 17 $ 0 32,285 (37,942)
Common stock, ending balance (in shares) at Mar. 31, 2023     173,842,712      
Treasury stock, ending balance (in shares) at Mar. 31, 2023       0    
Preferred stock, beginning balance (in shares) at Dec. 31, 2022   0        
Beginning balance at Dec. 31, 2022 4,052 $ 0 $ 17 $ 0 9,078 (5,043)
Common stock, beginning balance (in shares) at Dec. 31, 2022     173,524,360      
Treasury stock, beginning balance (in shares) at Dec. 31, 2022       0    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss) income and comprehensive (loss) income (11,005)          
Preferred stock, ending balance (in shares) at Sep. 30, 2023   0        
Ending balance at Sep. 30, 2023 24,144 $ 0 $ 17 $ 0 40,175 (16,048)
Common stock, ending balance (in shares) at Sep. 30, 2023     174,206,564      
Treasury stock, ending balance (in shares) at Sep. 30, 2023       0    
Preferred stock, beginning balance (in shares) at Mar. 31, 2023   0        
Beginning balance at Mar. 31, 2023 (5,640) $ 0 $ 17 $ 0 32,285 (37,942)
Common stock, beginning balance (in shares) at Mar. 31, 2023     173,842,712      
Treasury stock, beginning balance (in shares) at Mar. 31, 2023       0    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss) income and comprehensive (loss) income 22,331         22,331
Stock-based compensation 3,432       3,432  
Vested restricted stock units (in shares)     21,875      
Exercise of stock options (in shares)     189,072      
Exercise of stock options 674       674  
Preferred stock, ending balance (in shares) at Jun. 30, 2023   0        
Ending balance at Jun. 30, 2023 20,797 $ 0 $ 17 $ 0 36,391 (15,611)
Common stock, ending balance (in shares) at Jun. 30, 2023     174,053,659      
Treasury stock, ending balance (in shares) at Jun. 30, 2023       0    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss) income and comprehensive (loss) income (437)         (437)
Pre-Closing entity income tax adjustment (148)       (148)  
Stock-based compensation 3,474       3,474  
Vested restricted stock units (in shares)     31,180      
Exercise of stock options (in shares)     121,725      
Exercise of stock options 458       458  
Preferred stock, ending balance (in shares) at Sep. 30, 2023   0        
Ending balance at Sep. 30, 2023 $ 24,144 $ 0 $ 17 $ 0 40,175 (16,048)
Common stock, ending balance (in shares) at Sep. 30, 2023     174,206,564      
Treasury stock, ending balance (in shares) at Sep. 30, 2023       0    
Preferred stock, beginning balance (in shares) at Dec. 31, 2023 0 0        
Beginning balance at Dec. 31, 2023 $ (18,292) $ 0 $ 18 $ (2,154) 44,655 (60,811)
Common stock, beginning balance (in shares) at Dec. 31, 2023 175,020,471   175,377,711      
Treasury stock, beginning balance (in shares) at Dec. 31, 2023       357,240    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss) income and comprehensive (loss) income $ (9,406)         (9,406)
Stock-based compensation 6,259       6,259  
Vested restricted stock units (in shares)     363,793      
Exercise of stock options (in shares)     164,295      
Exercise of stock options 916       916  
Repurchase of common stock for net settlement of equity awards (in shares)       157,276    
Repurchase of common stock for net settlement of equity awards (1,494)     $ (1,494)    
Preferred stock, ending balance (in shares) at Mar. 31, 2024   0        
Ending balance at Mar. 31, 2024 $ (22,017) $ 0 $ 18 $ (3,648) 51,830 (70,217)
Common stock, ending balance (in shares) at Mar. 31, 2024     175,905,799      
Treasury stock, ending balance (in shares) at Mar. 31, 2024       514,516    
Preferred stock, beginning balance (in shares) at Dec. 31, 2023 0 0        
Beginning balance at Dec. 31, 2023 $ (18,292) $ 0 $ 18 $ (2,154) 44,655 (60,811)
Common stock, beginning balance (in shares) at Dec. 31, 2023 175,020,471   175,377,711      
Treasury stock, beginning balance (in shares) at Dec. 31, 2023       357,240    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss) income and comprehensive (loss) income $ (7,149)          
Exercise of stock options (in shares) 452,614          
Preferred stock, ending balance (in shares) at Sep. 30, 2024 0 0        
Ending balance at Sep. 30, 2024 $ (13,403) $ 0 $ 18 $ (7,776) 62,315 (67,960)
Common stock, ending balance (in shares) at Sep. 30, 2024 176,188,289   177,085,154      
Treasury stock, ending balance (in shares) at Sep. 30, 2024       896,865    
Preferred stock, beginning balance (in shares) at Mar. 31, 2024   0        
Beginning balance at Mar. 31, 2024 $ (22,017) $ 0 $ 18 $ (3,648) 51,830 (70,217)
Common stock, beginning balance (in shares) at Mar. 31, 2024     175,905,799      
Treasury stock, beginning balance (in shares) at Mar. 31, 2024       514,516    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss) income and comprehensive (loss) income (22,424)         (22,424)
Stock-based compensation 4,363       4,363  
Vested restricted stock units (in shares)     570,442      
Exercise of stock options (in shares)     236,129      
Exercise of stock options 816       816  
Repurchase of common stock for net settlement of equity awards (in shares)       244,751    
Repurchase of common stock for net settlement of equity awards (2,484)     $ (2,484)    
Preferred stock, ending balance (in shares) at Jun. 30, 2024   0        
Ending balance at Jun. 30, 2024 (41,746) $ 0 $ 18 $ (6,132) 57,009 (92,641)
Common stock, ending balance (in shares) at Jun. 30, 2024     176,712,370      
Treasury stock, ending balance (in shares) at Jun. 30, 2024       759,267    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss) income and comprehensive (loss) income 24,681         24,681
Stock-based compensation 5,005       5,005  
Vested restricted stock units (in shares)     320,431      
Exercise of stock options (in shares)     52,190      
Exercise of stock options 299       299  
Exercise of warrants (in shares)     163      
Exercise of warrants 2       2  
Repurchase of common stock for net settlement of equity awards (in shares)       137,598    
Repurchase of common stock for net settlement of equity awards $ (1,644)     $ (1,644)    
Preferred stock, ending balance (in shares) at Sep. 30, 2024 0 0        
Ending balance at Sep. 30, 2024 $ (13,403) $ 0 $ 18 $ (7,776) $ 62,315 $ (67,960)
Common stock, ending balance (in shares) at Sep. 30, 2024 176,188,289   177,085,154      
Treasury stock, ending balance (in shares) at Sep. 30, 2024       896,865